A history of head trauma may predict Parkinson’s disease progressionSeptember 20, 2022Traumatic Brain InjuryNeurology
‘Game changer’ semaglutide halves diabetes risk from obesitySeptember 19, 2022ObesityDiabetesCardiology
Atezolizumab doubles survival of NSCLC patients with poor performance statusSeptember 19, 2022Lung CancerOncology
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerLung CancerMelanomaRare Diseases
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerLung CancerMelanoma
New ESC guidelines for cutting CV risk in noncardiac surgerySeptember 15, 2022Colon and RectalNeurologyOncologyOrthopedicsPainStrokePulmonology
Sustained response at 2 years reported for newly approved oral psoriasis agentSeptember 15, 2022Dermatology
Pembro/chemo combo fails to improve event-free survival in head and neck cancerSeptember 14, 2022Oncology